ILMN(Illumina, Inc.) 的财务报表:医疗保健,诊断与研究。数据来自 SEC 公开申报与市场行情,不构成投资建议。
| 科目 | FY 截至 2022-01-02 | FY 截至 2023-01-01 | FY 截至 2023-12-31 | FY 截至 2024-12-29 | FY 截至 2025-12-28 |
|---|---|---|---|---|---|
| 营业收入 | $4.53B | $4.58B | $4.50B | $4.37B | $4.34B |
| 毛利润 | $3.15B | $2.97B | $2.74B | $2.86B | $2.87B |
| 营业利润 | −$123.00M | −$4.18B | −$1.07B | −$833.00M | $807.00M |
| 净利润 | $762.00M | −$4.40B | −$1.16B | −$1.22B | $850.00M |
| 经营现金流 | $545.00M | $392.00M | $478.00M | $837.00M | $1.08B |
| 自由现金流 | $337.00M | $106.00M | $283.00M | $709.00M | $931.00M |
| 摊薄每股收益 | $5.04 | $-28.00 | $-7.34 | $-7.69 | $5.45 |